Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.92 |
| ▸ | LMNA | P02545 | 3/20 | 0.92 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.92 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.92 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.71 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.71 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.71 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.71 |
| ▸ | PPARG | P37231 | 7/20 | 0.67 |
| ▸ | PPARD | Q03181 | 7/20 | 0.67 |
| ▸ | PPARA | Q07869 | 7/20 | 0.67 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.67 |
| ▸ | TLR2 | O60603 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | FABP4 | P15090 | 2/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pimelic Acid SCHEMBL28015918 | 1.00 | TSHR (0.92) | TSHRLMNANFKB1PMP22SLC22A6 | |
| SCHEMBL9851846 | 1.00 | TSHR (0.92) | TSHRLMNANFKB1PMP22SLC22A6 | |
| Octanedioate SCHEMBL8613636 | 1.00 | TSHR (0.92) | TSHRLMNANFKB1PMP22SLC22A6 | |
| Azelaic Acid SCHEMBL9318406 | 1.00 | TSHR (0.92) | TSHRLMNANFKB1PMP22SLC22A6 | |
| SCHEMBL25186232 | 0.96 | TSHR (1.00) | TSHRLMNANFKB1PMP22SLC22A6 | |
| Sebacic Acid SCHEMBL301600 | 0.96 | TSHR (1.00) | TSHRLMNANFKB1PMP22SLC22A6 | |
| Sebacic Acid SCHEMBL20500595 | 0.96 | TSHR (1.00) | TSHRLMNANFKB1PMP22SLC22A6 | |
| SCHEMBL21065467 | 0.96 | TSHR (1.00) | TSHRLMNANFKB1PMP22SLC22A6 | |
| Azelaic Acid SCHEMBL2724296 | 0.96 | TSHR (1.00) | TSHRLMNANFKB1PMP22SLC22A6 | |
| Adipic Acid SCHEMBL5475921 | 0.96 | TSHR (1.00) | TSHRLMNANFKB1PMP22SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040890-A | Pyroelectric polymer composite material and preparation method thereof | 都江堰市天兴硅业有限责任公司 | 2025-05-27 | — | — | CN | claimed |
| WO-2025029611-A1 | THERAPIES FOR DISEASES OF COPPER METABOLISM | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2025-02-06 | — | — | WO | claimed |
| WO-2012096655-A1 | COMPOSITIONS FOR TREATING CHRONIC VIRAL INFECTIONS | ANG SAM POON (US) | 2012-07-19 | — | — | WO | claimed |
| US-20120082720-A1 | Compositions For Treating Chronic Viral Infections | ANG SAM POON (US) | 2012-04-05 | — | — | US | claimed |
| US-20090041856-A1 | Methods for promoting hair growth | MURAD, INC. | 2009-02-12 | — | — | US | claimed |
| US-7452527-B2 | Methods of promoting hair growth | MURAD, INC. (US) | 2008-11-18 | — | — | US | claimed |
| US-20050241658-A1 | Composition to reduce or quit smoking addiction | LLOYDS INTERNATIONAL CREDIT, LLC | 2005-11-03 | — | — | US | claimed |
| US-6845777-B2 | Composition to reduce or quit smoking addiction | LLOYDS INTERNATIONAL CREDIT, LLC | 2005-01-25 | — | — | US | claimed |
| WO-2004087085-A1 | METHODS OF PROMOTING HAIR GROWTH | MURAD HOWARD (US) | 2004-10-14 | — | — | WO | claimed |
| US-6800292-B1 | FREE RADICAL NEUTRALIZATION; INCLUDES MOISTURIZERS | UNILEVER NV (NL) | 2004-10-05 | — | — | US | claimed |
| US-20020127256-A1 | Compositions and methods for treating dermatological disorders | MURAD HOWARD (US) | 2002-09-12 | — | — | US | claimed |
| EP-0812824-B1 | Process for preparing N-substituted maleimides | DAIHACHI CHEM IND (JP) | 2001-04-04 | — | — | EP | claimed |
| US-5972999-A | MIXTURE OF A SUGAR, ANTIOXIDANT AND AMINO ACID | UNILEVER NV (NL) | 1999-10-26 | — | — | US | claimed |
| US-5939076-A | Composition and method for treating or alleviating migraine headaches | ALLOCCA TECHICAL, INC. (US) | 1999-08-17 | — | — | US | claimed |
| WO-1999023881-A1 | COMPOSITION AND METHOD FOR PREVENTING OR ALLEVIATING MIGRAINE HEADACHES | ALLOCCA TECHNICAL, INC. (US) | 1999-05-20 | — | — | WO | claimed |
| US-5804168-A | PRIMARY ANTIOXIDANT, ANTIINFLAMMATORY AGENT, AND IMMUNITY-BOOSTING COMPONENT | UNILEVER NV (NL) | 1998-09-08 | — | — | US | claimed |
| US-5804594-A | APPLYING A COMPOSITION INCLUDING A SUGAR COMPOUND THAT IS CONVERTED TO A GLYCOSAMINOGLYCAN TO THICKEN SKIN, A PRIMARY ANTIOXIDANT TO INHIBIT FORMATION OF COLLAGENASE AND ELASTASE AND AT LEAST ONE AMINO ACID | UNILEVER NV (NL) | 1998-09-08 | — | — | US | claimed |
| US-5741913-A | REACTING MALEIC ANHYDRIDE WITH A PRIMARY AMINE IN MIXTURE OF PROTIC POLAR AND NONPOLAR SOLVENTS IN PRESENCE OF ACID CATALYST AND POLYMERIZATION INHIBITOR, EFFICIENCY | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 1998-04-21 | — | — | US | claimed |
| US-5723075-A | HEAT RESISTANT ABSORBERS WITH RESINS FOR SHIELDS | NIPPON PAPER INDUSTRIES CO., LTD. (JP) | 1998-03-03 | — | — | US | claimed |
| EP-0812824-A1 | Process for preparing N-substituted maleimides | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 1997-12-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120082720-A1 | Compositions For Treating Chronic Viral Infections | HAVCR2, FABP1, LIPC | TSHR 4819/4885LMNA 1999/4885NFKB1 568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.